[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ITFI20020107A1 - Composizioni farmaceutiche atte all'uso nel trattamento di patologie correlate all'azione di neutrofine e composti attivi in esse contenuti - Google Patents

Composizioni farmaceutiche atte all'uso nel trattamento di patologie correlate all'azione di neutrofine e composti attivi in esse contenuti

Info

Publication number
ITFI20020107A1
ITFI20020107A1 IT2002FI000107A ITFI20020107A ITFI20020107A1 IT FI20020107 A1 ITFI20020107 A1 IT FI20020107A1 IT 2002FI000107 A IT2002FI000107 A IT 2002FI000107A IT FI20020107 A ITFI20020107 A IT FI20020107A IT FI20020107 A1 ITFI20020107 A1 IT FI20020107A1
Authority
IT
Italy
Prior art keywords
treatment
active compounds
neutrofins
action
pharmaceutical compositions
Prior art date
Application number
IT2002FI000107A
Other languages
English (en)
Inventor
Antonio Guarna
Federico Cozzolino
Maria Torcia
Enrico Garaci
Original Assignee
Antonio Guarna
Federico Cozzolino
Maria Torcia
Enrico Garaci
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antonio Guarna, Federico Cozzolino, Maria Torcia, Enrico Garaci filed Critical Antonio Guarna
Priority to IT2002FI000107A priority Critical patent/ITFI20020107A1/it
Priority to PCT/EP2003/006471 priority patent/WO2004000324A1/en
Priority to CN038141558A priority patent/CN1662242B/zh
Priority to KR1020047020682A priority patent/KR101052345B1/ko
Priority to AU2003246559A priority patent/AU2003246559B2/en
Priority to DK03760652.2T priority patent/DK1551412T3/da
Priority to CA2489965A priority patent/CA2489965C/en
Priority to SI200332023T priority patent/SI1551412T1/sl
Priority to MXPA04012494A priority patent/MXPA04012494A/es
Priority to EP03760652A priority patent/EP1551412B1/en
Priority to NZ537791A priority patent/NZ537791A/en
Priority to US10/518,689 priority patent/US7625892B2/en
Priority to PT03760652T priority patent/PT1551412E/pt
Priority to DE60337019T priority patent/DE60337019D1/de
Priority to EA200401520A priority patent/EA014553B1/ru
Priority to PL03374372A priority patent/PL374372A1/xx
Priority to JP2004514784A priority patent/JP4728640B2/ja
Priority to ES03760652T priority patent/ES2366117T3/es
Priority to AT03760652T priority patent/ATE507833T1/de
Publication of ITFI20020107A1 publication Critical patent/ITFI20020107A1/it
Priority to IL165787A priority patent/IL165787A/en
Priority to CU20040289A priority patent/CU23538B7/es
Priority to HK06100469.6A priority patent/HK1080380A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT2002FI000107A 2002-06-19 2002-06-19 Composizioni farmaceutiche atte all'uso nel trattamento di patologie correlate all'azione di neutrofine e composti attivi in esse contenuti ITFI20020107A1 (it)

Priority Applications (22)

Application Number Priority Date Filing Date Title
IT2002FI000107A ITFI20020107A1 (it) 2002-06-19 2002-06-19 Composizioni farmaceutiche atte all'uso nel trattamento di patologie correlate all'azione di neutrofine e composti attivi in esse contenuti
US10/518,689 US7625892B2 (en) 2002-06-19 2003-06-18 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
PT03760652T PT1551412E (pt) 2002-06-19 2003-06-18 COMPOSIÇÕES FARMACjUTICAS PARA O TRATAMENTO DE DOENÇAS ASSOCIADAS ÀS NEUROTROFINAS
CN038141558A CN1662242B (zh) 2002-06-19 2003-06-18 用于治疗与神经营养蛋白相关的疾病的药物组合物
AU2003246559A AU2003246559B2 (en) 2002-06-19 2003-06-18 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
DK03760652.2T DK1551412T3 (da) 2002-06-19 2003-06-18 Farmaceutiske præparater til behandlingen af sygdomme beslægtet med neutrofiner
CA2489965A CA2489965C (en) 2002-06-19 2003-06-18 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
SI200332023T SI1551412T1 (sl) 2002-06-19 2003-06-18 Farmacevtski sestavki za zdravljenje bolezni, povezanih z nevrotrofini
MXPA04012494A MXPA04012494A (es) 2002-06-19 2003-06-18 Composiciones farmaceuticas para el tratamiento de enfermedades relacionadas a neurotrofinas.
DE60337019T DE60337019D1 (de) 2002-06-19 2003-06-18 Pharmazeutische zusammensetzungen zur behandlung von krankheiten im zusammenhang mit neurotrophinen
NZ537791A NZ537791A (en) 2002-06-19 2003-06-18 Pharmaceutical compositions comprising 3-aza-bicyclo[3.2.1]octane derivatives for the treatment of diseases related to neurotrophines
PCT/EP2003/006471 WO2004000324A1 (en) 2002-06-19 2003-06-18 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
KR1020047020682A KR101052345B1 (ko) 2002-06-19 2003-06-18 뉴로트로핀 관련 질환 치료용 약학 조성물
EP03760652A EP1551412B1 (en) 2002-06-19 2003-06-18 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
EA200401520A EA014553B1 (ru) 2002-06-19 2003-06-18 Фармацевтические композиции для лечения заболеваний, связанных с нейротрофинами
PL03374372A PL374372A1 (en) 2002-06-19 2003-06-18 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
JP2004514784A JP4728640B2 (ja) 2002-06-19 2003-06-18 ニューロトロフィン関連疾患の治療用医薬組成物
ES03760652T ES2366117T3 (es) 2002-06-19 2003-06-18 Composiciones farmacéuticas para el tratamiento de enfermedades relacionadas con neurotrofinas.
AT03760652T ATE507833T1 (de) 2002-06-19 2003-06-18 Pharmazeutische zusammensetzungen zur behandlung von krankheiten im zusammenhang mit neurotrophinen
IL165787A IL165787A (en) 2002-06-19 2004-12-15 Derivatives 8,6-Dioxa-3-Aza-Bicyclo [3.2.1] Octane-2-On for use in tomographic imaging and pharmaceutical preparations containing them
CU20040289A CU23538B7 (es) 2002-06-19 2004-12-16 Composiciones farmacéuticas para el tratamiento de enfermedades relacionadas a neurotrofinas
HK06100469.6A HK1080380A1 (en) 2002-06-19 2006-01-12 Pharmaceutical compositions for the treatment of diseases related to neurotrophines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002FI000107A ITFI20020107A1 (it) 2002-06-19 2002-06-19 Composizioni farmaceutiche atte all'uso nel trattamento di patologie correlate all'azione di neutrofine e composti attivi in esse contenuti

Publications (1)

Publication Number Publication Date
ITFI20020107A1 true ITFI20020107A1 (it) 2003-12-19

Family

ID=29798543

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002FI000107A ITFI20020107A1 (it) 2002-06-19 2002-06-19 Composizioni farmaceutiche atte all'uso nel trattamento di patologie correlate all'azione di neutrofine e composti attivi in esse contenuti

Country Status (22)

Country Link
US (1) US7625892B2 (it)
EP (1) EP1551412B1 (it)
JP (1) JP4728640B2 (it)
KR (1) KR101052345B1 (it)
CN (1) CN1662242B (it)
AT (1) ATE507833T1 (it)
AU (1) AU2003246559B2 (it)
CA (1) CA2489965C (it)
CU (1) CU23538B7 (it)
DE (1) DE60337019D1 (it)
DK (1) DK1551412T3 (it)
EA (1) EA014553B1 (it)
ES (1) ES2366117T3 (it)
HK (1) HK1080380A1 (it)
IL (1) IL165787A (it)
IT (1) ITFI20020107A1 (it)
MX (1) MXPA04012494A (it)
NZ (1) NZ537791A (it)
PL (1) PL374372A1 (it)
PT (1) PT1551412E (it)
SI (1) SI1551412T1 (it)
WO (1) WO2004000324A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2189462B9 (en) 2008-11-25 2012-06-13 Universita' Degli Studi di Firenze Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases
ITRM20110024A1 (it) 2011-01-24 2012-07-25 Consiglio Nazionale Ricerche Uso di antagonisti del recettore p75ntr e/o di agonisti del recettore trka per il trattamento delle malattie infiammatorie croniche.
ITFI20120062A1 (it) 2012-03-21 2013-09-22 Minerva Patents S A Componenti per il trattamento di malattie correlate a ischemia-riperfusione.
ITFI20130304A1 (it) * 2013-12-24 2015-06-25 Univ Firenze Bicyclic peptidomimetics for use in the treatment of fungal infections
CN109867686A (zh) * 2017-12-05 2019-06-11 中国科学院大连化学物理研究所 一种制备6,8-二氧-2-氮杂二环[3,2,1]辛-2-烯衍生物的方法
IT202000008125A1 (it) 2020-04-16 2021-10-16 Minerva Srl Acidi carbossilici 3-aza-biciclo[3.2.1]ottani e loro derivati per l’uso nel trattamento di infiammazioni
IT202200016614A1 (it) 2022-08-04 2024-02-04 Mimetech S R L Udonitrectag e sue formulazioni ad uso topico per l’uso nel trattamento di patologie dermatologiche

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504141A1 (fr) * 1981-04-21 1982-10-22 Delalande Sa Nouveaux derives dioxazabicycliques, leur procede de preparation et leur application en therapeutique
GR75910B (it) * 1981-04-21 1984-08-02 Delalande Sa
DE60042585D1 (de) * 2000-02-29 2009-09-03 Univ Firenze 3-Aza-6,8-dioxabicycloÄ3.2.1Üoctane und Analoga sowie diese enthaltende kombinatorische Bibliotheken

Also Published As

Publication number Publication date
SI1551412T1 (sl) 2011-09-30
KR20050024352A (ko) 2005-03-10
AU2003246559A1 (en) 2004-01-06
KR101052345B1 (ko) 2011-07-27
DK1551412T3 (da) 2011-08-15
JP4728640B2 (ja) 2011-07-20
EA200401520A1 (ru) 2005-12-29
CN1662242B (zh) 2010-12-22
US7625892B2 (en) 2009-12-01
IL165787A (en) 2014-04-30
HK1080380A1 (en) 2006-04-28
CU23538B7 (es) 2010-06-17
PT1551412E (pt) 2011-08-22
US20060069092A1 (en) 2006-03-30
MXPA04012494A (es) 2005-06-08
CA2489965A1 (en) 2003-12-31
NZ537791A (en) 2007-03-30
IL165787A0 (en) 2006-01-15
AU2003246559B2 (en) 2009-05-28
EP1551412B1 (en) 2011-05-04
EP1551412A1 (en) 2005-07-13
CA2489965C (en) 2012-07-31
EA014553B1 (ru) 2010-12-30
ATE507833T1 (de) 2011-05-15
DE60337019D1 (de) 2011-06-16
CN1662242A (zh) 2005-08-31
JP2005530834A (ja) 2005-10-13
PL374372A1 (en) 2005-10-17
ES2366117T3 (es) 2011-10-17
WO2004000324A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
KR102684364B1 (ko) 질환의 치료를 위한 kdm1a 저해제
NO20061701L (no) Tiazolderivater som cannabionoide reseptor modulatorer
WO2005113494A3 (en) Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
HK1080380A1 (en) Pharmaceutical compositions for the treatment of diseases related to neurotrophines
ES2164657T3 (es) Derivados aza-biciclicos puenteados como antagonistas de la sustancia p.
NO995006D0 (no) Nye forbindelser
BR0013143A (pt) Derivados de 3 (5) amino pirazol, processo para sua preparação e uso dos mesmos como agentes antitumorais
PL348715A1 (en) Carboxylic acids and carboxylic acid isosteres of n−heterocyclic compounds
MA27675A1 (fr) Derives de piperazine et leur utilisation dans le traitement de maladies neurologiques et psychiatriques
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
MXPA04005209A (es) Antagonistas del receptor de adenosina a2a.
BR0210392A (pt) Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto
ATE368040T1 (de) Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase- inhibitoren
DE69930662D1 (de) Humane rezeptortyrosinkinase
ATE269865T1 (de) Pyrazolo(3,4-g)chinoxaline als pdgf-rezeptor protein tyrosin-kinase inhibitoren
DE60004340D1 (de) Substituierte 1,4-dihydroindeno[1,2-c]pyrazole als inhibitoren von tyrosinkinase
ATE384708T1 (de) Piperazinderivate als aktivitätsmodulatoren der chemokinrezeptoren
BR9811348A (pt) Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas.
ATE425756T1 (de) Verwendung von carbamazepinderivaten zur behandlung von agitatio in demenspatienten
MEP59108A (en) Memno peptides, a process for their preparation and their use
MXPA04001201A (es) Derivados tetraciclicos de indol como ligandos del receptor de 5-ht.
HUP0302255A2 (hu) Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE355287T1 (de) 2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten
TNSN02035A1 (fr) Acides 3-heterocyclylpropanohydroxamiques nouveaux, compositions les contenant et procedes pour leur preparation.